why choose us

First received: May 28, 2023

Clinical Trial: A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gynaecological Malignancies

Study Type: INTERVENTIONAL


Official Title: Open, Multicenter Phase II Clinical Study of SHR-A1811 for Injection in the Treatment of Gynaecological Malignancies

Brief Summary: This is an open-label, two-part study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with a gynaecological malignancies.

Read more